Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000950688 | SCV001097017 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001010590 | SCV001170814 | benign | Hereditary cancer-predisposing syndrome | 2018-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000950688 | SCV002008653 | likely benign | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002282411 | SCV002046778 | benign | not specified | 2021-03-25 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002282411 | SCV002570184 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000950688 | SCV005225228 | likely benign | not provided | criteria provided, single submitter | not provided |